No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs16906191 |
chr9:92859704-92859705 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs552034883 |
chr9:92859709-92859710 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs527457803 |
chr9:92859729-92859730 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs388659 |
chr9:92859759-92859760 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs35621302 |
chr9:92859776-92859777 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs530811535 |
chr9:92859778-92859779 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs550665219 |
chr9:92859779-92859780 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs395437 |
chr9:92859808-92859809 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs73651746 |
chr9:92859810-92859811 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs193247730 |
chr9:92859823-92859824 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs395162 |
chr9:92859856-92859857 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs115392780 |
chr9:92859884-92859885 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs546452587 |
chr9:92859887-92859888 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs115985331 |
chr9:92859888-92859889 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs10992067 |
chr9:92859893-92859894 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs558809441 |
chr9:92859900-92859901 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs575313152 |
chr9:92859918-92859919 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs567319525 |
chr9:92859993-92859994 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs556371697 |
chr9:92860002-92860003 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs577959196 |
chr9:92860024-92860025 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs536451177 |
chr9:92860037-92860038 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs73651747 |
chr9:92860038-92860039 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs540299928 |
chr9:92860087-92860088 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs559731241 |
chr9:92860089-92860090 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs185715882 |
chr9:92860100-92860101 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs545424636 |
chr9:92860105-92860106 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs565192920 |
chr9:92860168-92860169 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs530825032 |
chr9:92860188-92860189 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs376963480 |
chr9:92860246-92860247 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs73651748 |
chr9:92860260-92860261 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs386736170 |
chr9:92860272-92860273 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs190177943 |
chr9:92860274-92860275 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs530166665 |
chr9:92860283-92860284 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs651982 |
chr9:92860287-92860288 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs566594143 |
chr9:92860305-92860306 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs370234330 |
chr9:92860323-92860324 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs146715442 |
chr9:92860392-92860393 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs181839177 |
chr9:92860393-92860394 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs542981409 |
chr9:92860453-92860454 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs184047160 |
chr9:92860472-92860473 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs554633110 |
chr9:92860481-92860482 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs569454659 |
chr9:92860493-92860494 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs140516200 |
chr9:92860506-92860507 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs538245065 |
chr9:92860539-92860540 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs533691750 |
chr9:92860540-92860541 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs553829238 |
chr9:92860640-92860641 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs573361254 |
chr9:92860641-92860642 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs111315859 |
chr9:92860649-92860650 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs576468766 |
chr9:92860653-92860654 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs188719096 |
chr9:92860681-92860682 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|